What if one of the most toxic yet powerful cancer drugs could be made safer, more effective, and longer-lasting? That’s precisely the question scientists and pharmaceutical leaders are answering with liposomal technology. The Liposomal Doxorubicin Market is at the forefront of this transformation—delivering an advanced form of chemotherapy that minimizes side effects while...